Literature DB >> 17491976

Age-related macular disease: aetiology and clinical management.

A C Bird1.   

Abstract

Entities:  

Year:  1999        PMID： 17491976      PMCID： PMC1705992     

Source DB:  PubMed          Journal:  Community Eye Health        ISSN： 0953-6833


× No keyword cloud information.
  4 in total

1.  Is the incidence of registrable age-related macular degeneration increasing?

Authors:  J Evans; R Wormald
Journal:  Br J Ophthalmol       Date:  1996-01       Impact factor: 4.638

2.  Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Macular Photocoagulation Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1986-05

3.  Macular lesions predisposing to senile disciform macular degeneration.

Authors:  M Yuzawa; K Hagita; T Egawa; H Minato; M Matsui
Journal:  Jpn J Ophthalmol       Date:  1991       Impact factor: 2.447

4.  Decreasing stromal iris pigmentation as a risk factor for age-related macular degeneration.

Authors:  F G Holz; B Piguet; D C Minassian; A C Bird; R A Weale
Journal:  Am J Ophthalmol       Date:  1994-01-15       Impact factor: 5.258
  4 in total
  2 in total

Review 1.  A Historical Analysis of the Quest for the Origins of Aging Macula Disorder, the Tissues Involved, and Its Terminology.

Authors:  Paulus T V M de Jong
Journal:  Ophthalmol Eye Dis       Date:  2016-11-01

2.  Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trial.

Authors:  Martijn S Visser; Sankha Amarakoon; Tom Missotten; Reinier Timman; Jan J V Busschbach
Journal:  Qual Life Res       Date:  2020-07-14       Impact factor: 4.147
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.